BioCentury
ARTICLE | Company News

KellBenx, OncoVista deal

June 28, 2010 7:00 AM UTC

OncoVista's AdnaGen AG subsidiary granted KellBenx an option to license exclusive, worldwide rights to undisclosed mAbs against fetal erythroid cells for use in developing prenatal diagnostics. Kellb...